Abstract:AIM: To evaluate the clinical significance of systemic inflammatory responses and hypercoagulability in the pathogenesis of diabetic retinopathy(DR)and its vision-threatening complications including diabetic macular edema(DME)and neovascular glaucoma(NVG), and to explore the diagnostic efficacy of routine and novel hematological indices for early DR detection and risk stratification.
METHODS:DR patients and healthy control participants who underwent physical examinations in our hospital were enrolled in this cross-sectional study. All participants underwent routine peripheral blood tests. Conventional hematological parameters and novel composite indices, including mean platelet volume-to-lymphocyte count ratio(PMLR)and mean platelet volume×neutrophil count/lymphocyte count(PMNLR), were calculated and compared between groups. Subgroup analyses were conducted within the DR cohort to compare patients with uncomplicated DR versus those with DME or NVG. Logistic regression analysis was used to identify risk factors associated with DR and its complications. Receiver operating characteristic(ROC)curves were applied to evaluate the diagnostic efficacy of single and combined hematological markers, with optimal cut-off values, sensitivity, specificity, area under the curve(AUC)and 95% confidence interval(CI)calculated.
RESULTS: A total of 497 DR patients(243 males and 254 females; mean age 58.01±11.13 y)and 858 healthy controls(473 males and 385 females; mean age 58.05±12.14 y)were enrolled. The DR group exhibited significantly higher levels of white blood cell count, neutrophil count(NEU), neutrophil-to-lymphocyte ratio(NLR), and systemic immune-inflammation index(SII), and mean platelet volume, along with significantly lower platelet counts, compared to the healthy group(all P<0.05). Among DR patients, hematological profiles differed across subgroups: the DME group had higher NEU, NLR, and PMNLR than the simple DR group, while the NVG group had higher NEU, NLR, SII, and PMNLR than the simple DR group(all P<0.05), suggesting distinct hematological profiles among DR subgroups. Multivariate logistic regression showed that NEU, monocyte count(MONO), PMLR, and SII were risk factors for DR(all OR >1)and lymphocyte count(LYM)was protective factor for DR(OR=0.326). ROC curve analysis revealed that NLR, NEU, and PMNLR exhibited favorable sensitivity and specificity for DR diagnosis, with a combined multi-marker model(NLR+NEU+PMNLR)yielding improved diagnostic accuracy(AUC=0.743, 95%CI: 0.716-0.770).
CONCLUSION:Inflammation and hypercoagulability play critical roles in the development of DR and its complications. Blood markers such as NLR, NEU, SII, PMLR, and PMNLR may serve as valuable tools for early diagnosis and risk stratification of DR. Future research should focus on longitudinal monitoring of these markers during disease progression and validate their clinical utility across diverse populations through multi-center studies.